Emily M. Leproust Twist Bioscience Corp (TWST) insider trading activity

Emily M. Leproust is Chief Executive Officer of Twist Bioscience Corp. Currently has a direct ownership of 481,918 shares of TWST, which is worth approximately $20 Million. The most recent transaction as insider was on Feb 25, 2021, when has been sold 45,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 482K

4.52% 3M change

33.78% 12M change

Total Value Held $20 Million

Emily M. Leproust Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2021	SELL Bona fide gift	-	45,000 Reduced 14.26%	270,556 Common Stock
Feb 19 2021	SELL Payment of exercise price or tax liability	$453,486 $150.81 p/Share	3,007 Reduced 0.94%	315,556 Common Stock
Feb 12 2021	SELL Open market or private sale	$334,860 $167.43 p/Share	2,000 Reduced 0.62%	318,188 Common Stock
Jan 22 2021	SELL Payment of exercise price or tax liability	$192,165 $190.64 p/Share	1,008 Reduced 0.25%	395,188 Common Stock
Jan 20 2021	SELL Bona fide gift	$15,597,750 $207.97 p/Share	75,000 Reduced 18.98%	320,188 Common Stock
Jan 20 2021	SELL Open market or private sale	$1,051,000 $210.2 p/Share	5,000 Reduced 1.25%	396,196 Common Stock
Jan 19 2021	SELL Open market or private sale	$4,015,600 $200.78 p/Share	20,000 Reduced 4.75%	401,196 Common Stock
Jan 14 2021	SELL Open market or private sale	$1,829,200 $182.92 p/Share	10,000 Reduced 2.32%	421,196 Common Stock
Jan 12 2021	SELL Open market or private sale	$333,260 $166.63 p/Share	2,000 Reduced 0.46%	431,196 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$107,804 $141.29 p/Share	763 Reduced 0.18%	433,196 Common Stock
Dec 24 2020	BUY Exercise of conversion of derivative security	$31,535 $5.95 p/Share	5,300 Added 1.21%	433,959 Common Stock
Dec 23 2020	SELL Open market or private sale	$848,700 $169.74 p/Share	5,000 Reduced 1.15%	428,659 Common Stock
Dec 22 2020	SELL Open market or private sale	$802,300 $160.46 p/Share	5,000 Reduced 1.14%	433,659 Common Stock
Dec 21 2020	SELL Open market or private sale	$1,504,100 $150.41 p/Share	10,000 Reduced 2.23%	438,659 Common Stock
Dec 18 2020	SELL Open market or private sale	$290,880 $145.44 p/Share	2,000 Reduced 0.44%	448,659 Common Stock
Dec 15 2020	SELL Open market or private sale	$9,340,099 $133.43 p/Share	70,000 Reduced 13.44%	450,659 Common Stock
Nov 20 2020	SELL Payment of exercise price or tax liability	$347,489 $115.56 p/Share	3,007 Reduced 0.57%	520,659 Common Stock
Oct 24 2020	SELL Payment of exercise price or tax liability	$346,631 $85.97 p/Share	4,032 Reduced 0.76%	523,666 Common Stock
Sep 21 2020	SELL Bona fide gift	-	80,000 Reduced 13.16%	527,698 Common Stock

Also insider at

SMFR

Sema4 Holdings Corp. Healthcare

EML

Emily M. Leproust

Chief Executive Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Value

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST

Account